Evidence map›Paper›PMID 42824905›Full record

ArticleScience and technology of advanced materials2026

Dual-modal Fe-MOF-derived piezoelectric nanofibers enable combinatorial tumor suppression via tumor treating fields and magnetic hyperthermia.

Shiqin Dai, Ahmed Nabil, Mitsuhiro Ebara

Abstract read
In one paragraph

Article in Science and technology of advanced materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shiqin DaiResearch Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), Tsukuba, Ibaraki, Japan.ORCID https://orcid.org/0009-0000-3070-8358
Ahmed NabilResearch Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), Tsukuba, Ibaraki, Japan.
Mitsuhiro EbaraResearch Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), Tsukuba, Ibaraki, Japan.ORCID https://orcid.org/0000-0002-7906-0350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is among the most lethal primary brain tumors, owing to its highly invasive nature and pronounced resistance to conventional therapies. Emerging physical treatment modalities, such as tumor treating fields (TTFs), offer drug-free therapeutic alternatives. However, their clinical efficacy remains constrained by limited field strength and poor spatial control in deep brain regions. Moreover, a single physical stimulus is often inadequate to achieve sustained tumor suppression, highlighting the need for complementary therapeutic modalities. Herein, we report a multifunctional therapeutic platform in which iron-based metal-organic framework (Fe-MOF)-derived porous carbon is incorporated into piezoelectric polyacrylonitrile (PAN) nanofibers. This system enables ultrasound-triggered local electric field generation in combination with alternating magnetic field (AMF)-driven magnetic hyperthermia. The engineered nanofibers exhibited enhanced piezoelectric performance under ultrasound stimulation, alongside efficient heat generation under magnetic excitation. In vitro studies demonstrated pronounced suppression of GBM cell migration and induction of apoptosis, arising from the combinatorial effects of localized electric field stimulation and thermal therapy. Collectively, this work establishes a dual-modal therapeutic strategy that overcomes key limitations of standalone therapies and offers a promising platform for effective GBM treatment.

Indexed as

combinatorial therapyGlioblastomamagnetic hyperthermiaMOF-derived porous carbonnanofiberstumor treating fields therapy

Identifiers

PMID42824905
PMCPMC13629815

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.